Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Lantern Pharma
LTRN
$32.4M
| $187K | ﹤0.01% |
43,800
+5,700
| +15% | +$20.1K |
|
|
MAGN
3152
Magnera Corp
MAGN
$430M
| $187K | ﹤0.01% |
7,408
+2,646
| +56% | +$55.7K |
|
3153
authID Inc
AUID
$8.36M
| $186K | ﹤0.01% |
+19,628
| New | +$154K |
|
3154
Caribou Biosciences
CRBU
$156M
| $186K | ﹤0.01% |
+32,400
| New | +$160K |
|
|
PROF
3155
Profound Medical
PROF
$242M
| $186K | ﹤0.01% |
+21,900
| New | +$208K |
|
3156
Rockwell Medical
RMTI
$30.2M
| $186K | ﹤0.01% |
9,820
+8,416
| +599% | +$158K |
|
|
VWE
3157
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
| $186K | ﹤0.01% |
369,400
+351,500
| +1,964% | +$200K |
|
|
CMLS
3158
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $183K | ﹤0.01% |
34,400
+13,100
| +62% | +$66.2K |
|
3159
Beasley Broadcasting Group
BBGI
$42.2M
| $182K | ﹤0.01% |
10,356
+1,408
| +16% | +$21.9K |
|
3160
Skillful Craftsman
EDTK
$14.3M
| $182K | ﹤0.01% |
144,200
-8,400
| -6% | -$8.07K |
|
|
STLN
3161
Starling Oncology, Inc. Common Stock
STLN
$659M
| $182K | ﹤0.01% |
89,300
+17,000
| +24% | +$29.5K |
|
3162
United Maritime
USEA
$25.8M
| $182K | ﹤0.01% |
73,616
+43,616
| +145% | +$104K |
|
3163
Pro-Dex
PDEX
$215M
| $181K | ﹤0.01% |
+10,340
| New | +$173K |
|
3164
VanEck Preferred Securities ex Financials ETF
PFXF
$2.49B
| $181K | ﹤0.01% |
+10,522
| New | +$174K |
|
3165
WidePoint Corp
WYY
$92.8M
| $180K | ﹤0.01% |
77,750
+47,850
| +160% | +$86.1K |
|
|
GPMT
3166
Granite Point Mortgage Trust
GPMT
$56.9M
| $179K | ﹤0.01% |
30,120
-134,980
| -82% | -$680K |
|
3167
a.k.a. Brands
AKA
$115M
| $178K | ﹤0.01% |
22,094
+4,219
| +24% | +$32.6K |
|
3168
Genius Sports
GENI
$2.23B
| $178K | ﹤0.01% |
28,800
-592,300
| -95% | -$3.19M |
|
|
ICD
3169
DELISTED
Independence Contract Drilling, Inc.
ICD
| $178K | ﹤0.01% |
72,800
-1,178
| -2% | -$3.03K |
|
3170
Forafric Global
AFRI
$300M
| $176K | ﹤0.01% |
+16,600
| New | +$184K |
|
3171
Idaho Strategic Resources
IDR
$516M
| $176K | ﹤0.01% |
+27,800
| New | +$154K |
|
3172
Magyar Bancorp
MGYR
$126M
| $176K | ﹤0.01% |
15,700
+3,000
| +24% | +$29.6K |
|
3173
OPAL Fuels
OPAL
$68.3M
| $176K | ﹤0.01% |
+31,800
| New | +$196K |
|
3174
OptimumBank Holdings
OPHC
$117M
| $176K | ﹤0.01% |
42,060
+560
| +1% | +$1.9K |
|
|
NAK
3175
Northern Dynasty Minerals
NAK
$930M
| $175K | ﹤0.01% |
541,206
+120,326
| +29% | +$40K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.